Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Arena Pharmaceuticals' Q1 Loss Widens 34% Despite Belviq's Sales Surge
Arena Pharmaceuticals' Q1 Loss Widens 34% Despite Belviq's Sales Surge
Arena Pharmaceuticals' Q1 Loss Widens 34% Despite Belviq's Sales Surge
Submitted by
admin
on May 12, 2014 - 5:24pm
Source:
Motley Fool
News Tags:
earnings
Arena Pharmaceuticals
Headline:
Arena Pharmaceuticals' Q1 Loss Widens 34% Despite Belviq's Sales Surge
Do Not Allow Advertisers to Use My Personal information
